Taub Rebecca
SEC CIK 1423898 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Pres, CMO, R, D, Dir | 452.7K | — | $68.17M | 27 | 2023-01-16 | 2026-06-17 |
Most active insiders at MDGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRIEDMAN PAUL A | Dir | — | $26.66M |
| 2 | Taub Rebecca | Dir | — | $21.68M |
| 3 | Sibold William John | Pres, CEO, Dir | — | $10.48M |
| 4 | BATE KENNETH | Dir | — | $8.03M |
| 5 | Levy Richard S | Dir | — | $7.36M |
| 6 | Dier Mardi | EVP, CFO | — | $3.77M |
| 7 | Huntsman Carole | Chief Commercial Off | — | $1.71M |
| 8 | Soergel David | Chief Medical Off | — | $952.0K |
| 9 | Kelley Shannon T | GC | — | $841.6K |
| 10 | Thakkar Rita | CAO | — | — |
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-18 16:23 | 2026-06-17 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | A - Grant | $0.00 | +454 | 452.7K | +0.1% | $0 |
| 2026-03-06 | 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | S - Sale | $431.94 | -491 | 452.2K | -0.1% | -$212.1K | |
| 2026-01-26 | 2026-01-26 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | S - Sale | $492.42 | -647 | 452.7K | -0.1% | -$318.6K | |
| 2026-01-20 | 2026-01-20 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | S - Sale | $490.77 | -2,238 | 453.4K | -0.5% | -$1.10M | |
| DM | 2026-01-13 | 2026-01-09 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | S - Sale+OE | $550.33 | -240 | 455.8K | -0.1% | -$132.1K |
| D | 2026-01-13 | 2026-01-09 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | M - OptEx | $15.80 | +240 | 455.8K | +0.1% | +$3,792 |
| DM | 2026-01-13 | 2026-01-09 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | S - Sale+OE | $522.40 | -18.4K | 458.9K | -4% | -$9.62M |
| D | 2026-01-13 | 2026-01-09 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | M - OptEx | $15.80 | +18.4K | 474.0K | +4% | +$290.9K |
| DM | 2025-12-12 | 2025-12-10 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | S - Sale+OE | $552.15 | -18.6K | 478.8K | -4% | -$10.30M |
| D | 2025-12-12 | 2025-12-10 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | G - Gift | $0.00 | -5,455 | 455.6K | -1% | $0 |
| D | 2025-12-12 | 2025-12-10 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | M - OptEx | $15.80 | +18.6K | 479.7K | +4% | +$294.7K |
| DM | 2025-08-13 | 2025-08-11+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | M - OptEx | $9.45 | +46.5K | 504.3K | +10% | +$439.1K |
| DM | 2025-08-13 | 2025-08-11+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | S - Sale+OE | $355.31 | -46.5K | 461.7K | -9% | -$16.51M |
| D | 2025-07-22 | 2025-07-18 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | S - Sale+OE | $350.01 | -1,000 | 461.0K | -0.2% | -$350.0K |
| D | 2025-07-22 | 2025-07-18 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | M - OptEx | $9.45 | +1,000 | 462.0K | +0.2% | +$9,450 |
| DM | 2025-07-18 | 2025-07-16+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | S - Sale+OE | $353.19 | -29.1K | 461.0K | -6% | -$10.28M |
| DM | 2025-07-18 | 2025-07-16+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Dir | M - OptEx | $9.45 | +29.1K | 487.5K | +6% | +$275.0K |
| D | 2025-03-07 | 2025-03-05 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres, CMO, R, D, Dir | A - Grant | $0.00 | +4,382 | 461.0K | +1.0% | $0 |
| 2025-01-27 | 2025-01-24 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres, CMO, R, D, Dir | S - Sale | $335.24 | -648 | 456.7K | -0.1% | -$217.2K | |
| 2025-01-17 | 2025-01-17 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres, CMO, R, D, Dir | S - Sale | $273.41 | -1,689 | 457.3K | -0.4% | -$461.8K | |
| DMT | 2024-04-10 | 2024-04-08 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres, CMO, R, D, Dir | S - Sale+OE | $245.99 | -2,676 | 459.0K | -0.6% | -$658.3K |
| DT | 2024-04-10 | 2024-04-08 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres, CMO, R, D, Dir | M - OptEx | $9.45 | +2,676 | 461.7K | +0.6% | +$25.3K |
| DM | 2024-04-05 | 2024-04-03+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres, CMO, R, D, Dir | M - OptEx | $9.45 | +73.9K | 486.8K | +18% | +$698.2K |
| DM | 2024-04-05 | 2024-04-03+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres, CMO, R, D, Dir | S - Sale+OE | $243.92 | -73.9K | 484.2K | -13% | -$18.02M |
| D | 2024-01-25 | 2024-01-23 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres, CMO, R, D, Dir | A - Grant | $0.00 | +5,786 | 20.8K | +39% | $0 |
| 2024-01-18 | 2024-01-16 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres, CMO, R, D, Dir | F - Tax | $243.92 | -1,546 | 15.0K | -9% | -$377.1K | |
| 2023-01-18 | 2023-01-16 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres, CMO, R, D, Dir | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations